Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | AGXT | P21549 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | FBP1 | P09467 | 1/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2284428 | 0.79 | TAAR1 (0.49) | CYP3A4IDO1AGXT | |
| SCHEMBL6272279 | 0.78 | KDM4E (0.51) | KDM4ELMNA | |
| SCHEMBL2734239 | 0.78 | — | — | |
| SCHEMBL11266330 | 0.77 | KMT2A (0.52) | KDM4ELMNA | |
| SCHEMBL5584320 | 0.77 | TAAR1 (0.46) | KDM4ETSHRALOX15ALDH1A1LMNA | |
| SCHEMBL27972546 | 0.74 | ALDH1A1 (0.47) | TSHRALDH1A1LMNAUSP2PGR | |
| Dimethylamine SCHEMBL5971936 | 0.72 | USP2 (0.52) | KDM4ETSHRALOX15ALDH1A1LMNA | |
| SCHEMBL15842311 | 0.71 | PGR (0.42) | ALDH1A1PGRHPGD | |
| SCHEMBL2536519 | 0.70 | ERCC5 (0.50) | ALDH1A1HPGD | |
| SCHEMBL4857267 | 0.69 | TAAR1 (0.44) | KDM4ETSHRALOX15ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10703744-B2 | Process for preparation of luliconazole | GLENMARK LIFE SCIENCES LIMITED (IN) | 2020-07-07 | — | — | US | disclosed |
| US-20170362212-A1 | PROCESS FOR PREPARATION OF LULICONAZOLE | GLENMARK LIFE SCIENCES LIMITED (IN) | 2017-12-21 | — | — | US | disclosed |
| EP-3230280-A1 | PROCESS FOR PREPARATION OF LULICONAZOLE | Glenmark Pharmaceuticals Limited (IN) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016092478-A1 | PROCESS FOR PREPARATION OF LULICONAZOLE | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2016-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362212-A1 | PROCESS FOR PREPARATION OF LULICONAZOLE | LSS, CYP51A1, THPO | KDM4E 3191/4885TSHR 4190/4885ALOX15 2691/4885 |
| US-10703744-B2 | Process for preparation of luliconazole | LSS, CYP51A1, THPO | KDM4E 3191/4885TSHR 4190/4885ALOX15 2691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.